Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK

OBJECTIVE: The study objective of this analysis was to determine the cost-effectiveness of vaborem (meropenem-vaborbactam) compared to the best available therapy (BAT) in adult patients with carbapenem-resistant Enterobacteriaceae—Klebsiella pneumoniae carbapenemase (CRE-KPC) infections from the per...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlachaki, Ioanna, Zinzi, Daniela, Falla, Edel, Mantopoulos, Theo, Guy, Holly, Jandu, Jasimran, Dodgson, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453464/
https://www.ncbi.nlm.nih.gov/pubmed/34546484
http://dx.doi.org/10.1007/s10198-021-01375-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453464/
https://www.ncbi.nlm.nih.gov/pubmed/34546484
http://dx.doi.org/10.1007/s10198-021-01375-0

Ejemplares similares